FILE - Filmmaker David Lynch poses for a portrait in his private screening room in Los Angeles on Sept. 9, 2010. (AP Photo/Chris Pizzello, file) ...

Now, though, Lilly chief executive officer David Ricks says he is considering expanding the vial offering. Lilly has been offering the vials only to patients paying on their own without insurance ...

Here's a closer look at his eye-popping numbers. Before he attended Alabama, Hurts was already known for his work as a powerlifter. Heading into his freshman season, Hurts could squat and ...

David Dobrik made his long-awaited return to YouTube after a three-year hiatus with a brand new beach bod — but bodybuilder Greg Doucette isn’t convinced he achieved it naturally. Dobrik ...

12:20 p.m. ET Late Tuesday, Eli Lilly CEO David Ricks took to the stage at the J.P. Morgan Healthcare Conference to explain his views of the booming GLP-1 space. Earlier in the day, Lilly warned ...

Eli Lilly forecasts $45 billion in 2024 revenue, a 32% growth but $400 million below Q3 guidance. Mounjaro and Zepbound expected to contribute $3.5 billion and $1.9 billion, respectively, to 2024 ...

Eli Lilly CEO David Ricks joins 'Squawk on the Street' to discuss the company's drug pipeline, 2025 outlook, state of the weight loss drugs market, status of the weight loss drug pill, revised ...

SAN FRANCISCO — Eli Lilly CEO Dave Ricks on Tuesday said he believed the company could find “significant common cause” with the incoming Trump administration, including on issues around ...

CEO David Ricks said last quarter’s 45% growth in Lilly’s revenue for its Mounjaro diabetes treatment, Zepbound obesity injections and other products in the incretin market wasn’t as big as ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to be approved as soon as early next year, CEO David Ricks told Bloomberg. Eli Lilly and Novo Nordisk, which dominate the market ...